收藏 分销(赏)

股权激励市场实践研究报告.pdf

上传人:Stan****Shan 文档编号:1246334 上传时间:2024-04-19 格式:PDF 页数:57 大小:775.85KB
下载 相关 举报
股权激励市场实践研究报告.pdf_第1页
第1页 / 共57页
股权激励市场实践研究报告.pdf_第2页
第2页 / 共57页
股权激励市场实践研究报告.pdf_第3页
第3页 / 共57页
股权激励市场实践研究报告.pdf_第4页
第4页 / 共57页
股权激励市场实践研究报告.pdf_第5页
第5页 / 共57页
点击查看更多>>
资源描述

1、0!2021-2022!#$%&()$*+SAAS+,-./0123&456(2789:;#$?ABCDE2FGHIJKLMNOP&QFGR%STUVWXY!#Z_abcJdefg?IPO2hijTZ(g+fklm+nopfk3&DqrsLMNOt4uvPfkwx%&yz%&|78(2“”2NOD.?a78yz2LMNOvPyz+782LMNO2C?ZHI+XIPOHI,2HI-DE2%&+2+789:2?2=+2P6FsDE%&2LMNOLMNO&Qbo2022LMNO1!#$03!#$%&()*+,-./012345 6,-78 6 9:;6,-0?6,-A 6 BCDE?6 DEFG2%

2、&#$22!#$%HIJ()*+,-./012345 6,-78 6 9:;6,-0?6,-A 6 BCDE?6 DEFG()*#$40!#$%KLM()*+,-./012345 6,-78 6 9:;6,-0?6,-A 6 BCDE?6 DEFG!Content!#$TECHNOLOGY!#$%&()*4?NO|%MMCu2K31%3&%MM19%3&z0a2L=!NOCuHI2K#$%|nop3&C%(IPO(3-6!SAAS3&C%IPO(4-7!u)|*+,#$?u)-.P3.21%*/+,#$?u)-.P6.08%;|69%2*+,#$?uM0K%M38%2*/+,#$?uL12.3

3、?-?NO|%MMK40aL2KzL%|nop3&zL%&C(1!5(&670|33%2*#$?(8vIPO9P:&670!;)|*+,#$?!;)-.P2%-3%*/+,#$?45?NO|XY!VW#$%&.ABC0aL2KDE80%!;)|X3!8vIPO2nop3&2021!;)-.P2.12%LFjGKH&IJ-.P5.37%(K)|(K)-.P12.2%NOaL|#$?(NOaLMNP14.6%OSAASPQR3&NOaLMNC20%ST;|*+,*/+,#$?;3ULVWO*/SAAS?(L;&P2.210%-20%!1#$SAAS%&(/)*+,-./012%&345678912

4、,-.:;?ABC,-!2DEFGH78IJK!LM3DE.DNFGH78IJK!LM3DN.OPAQAHQ,-!3RS78TU8V=RS78SWXYZRS78SWUQ6+,-.F.XY!Z#$%&122_#$?MNnop+SAAS+-./0PQRaZ%&1O7-.bAIcd3&27_efZCSAAS3&g#$?23&gnop3&100%P*+,SAAS3&44%P*+,-./0PQR3&hiZP*/+,jFkl77%23&2019!m8vFjF.XYlnop3&DE50nop.2?5(LMq,Z互联网SAAS智能硬件半导体大于$100亿$50亿-$100亿(含)$10亿-$50亿(含)$10

5、亿及以下100%44%14%6%56%86%94%互联网SAAS智能硬件半导体境外境内nopSAAS-./0 PQR2019BNOPQRST2019BUVPQRSTFkZaZ%&Zrs互联网,34%SAAS,15%智能硬件,24%半导体,27%7-.btucd23&(/0!1_$9BaQbOcQdefSAgBaQbRSghTijk9BaQblmRSUnh-ojk9BaQblmPRSUpqrWsXtHuvwxyzWsX|E9X9WsXp$wf9*“9U*.”3J78Iwn|7f9pIPO-NHRS78N.78I9p2021789 7*+,2#$?(M2KvPewxVXY!y*2zNO2K$p20

6、19!m8vIPO2*+,#$?(8vIPO2?|0K%MMLO53%223&C(0K3&C(0K%M2M%M2MVWNOK28vIPO2?EK%MM0aL2?42019!m8vIPO2*+,#$?27%2?EK!NORK!NO2?VWIPOR2R8vM2?42019!(8vF2*+,#$?(0K2NO160%53%43%23%78%30%52%4%期权-常规行权价期权-极低行权价限制性股票-0对价限制性股票-非0对价2019年至今完成IPO的科技公司2019年之前完成IPO的科技公司27%44%EK=!NO!NO23&90%41%IPO-3IPO-2IPO-1IPO-02021OM)!#$%

7、&()*+,-./0123482019!(8vIPO2*+,#$?j2021!10K2NO65%46%18%11%18%89%0%20%40%60%80%100%IPO-3IPO-2IPO-1IPO-02021M-%MM-%ML-0aL-0a!1RH78378IRSj9.IPO-NHRS78N.78I9p20217892019!m8vIPO2*+,#$?j2021!10K2NO2019!m8vIPO2*+,#$?LMNO38%23&0K%M2MJa8vIPO2#$?#$4b65%c31%K%M2Ma8vIPO2#$?#$b18%cj0a2L2K22021!73%22019!m8vIPO2#$?

8、K0a2L38%53%31%33%19%73%0%20%40%60%80%100%IPO-3IPO-2IPO-1IPO-02021M-%MM-%ML-0aL-0a!#$%&()*+5,-./01267!178wBaQb-0X-.3$!2T8V=TQXY2/(UQ+UQ9*+,#$?2NOU.dg.#$%M2MK5VW.Y.XY5L2K*+,#$?X5!0K2NO1bSc*+,#$?X5!%.XY2-.-nopbTc-50 100 150 200 250 300-100%-80%-60%-40%-20%0%20%40%60%80%100%20172018201920202021%.XYnopM-

9、%MM-%ML-0a!#$%&()*5,-./01234!1s-78IWsHJQbs.&378IWsQ9fps-IPOH78Is.|78Ws9f$wf9*78IQsf9DN4U*.”3J78Iwn|7f910*/+,2#$?90%23&(-0KL2NO16%23&P2MC(i8v%M8%23&(MEIPO=XIPOMEIPO212%*/+,#$3&(0K2NO1*/+,#$?jIPO(!0K2NOZrs90%16%8%6%出资入股期权-上市前行权期权-带过IPO限制性股票0%20%40%60%80%100%IPO-3IPO-2IPO-1LM-(%MM-EIPOL!8#$%&()*+,-./01

10、234123456!1DEFG49.DEFG4./012-A:;-W-)DNFG,-.pRTR11a*#$?2”%&C%(#$?%CIPO(5!STb-.cOnop3&CIPO(4!4ub-.cSAAS3&%aIPO%*+,#$?%“”%12!;b.-!c(3)(1)13科技公司整体互联网SAAS25分位50分位75分位%#$?%“”F2!;b.-!c(8)(6)(4)(2)0科技公司整体互联网SAAS半导体智能硬件25分位50分位75分位FF%&(9:;?!18V.78I9V.78TQXYnSWUQ9V12*+,#$3&0aL%“”F2!;b.-!c*+,#$3&0aL%a2?.1XYb.-

11、nopc*+,#$?z0aL%2-.C(D1!O2019!(8vIPO2nop3&z0aL%P=(nop3&z0aLa2?.XY-.C72nop!#$%&(9:AB0CDEFGHI0=?(7)(2)3科技公司整体互联网SAAS25分位50分位75分位0100200300科技公司整体互联网SAAS25分位50分位75分位nop3&0aL%“”F2!;b.-!c(7)(5)(3)(1)132019年至今完成IPO2019年之前完成IPO25分位50分位75分位!1_$Qsfjk9!2_$Qsf913(3P1!:4!-P2ddPp*#$?(,2021!31Zrs0%50%100%0!1!2!3!5!

12、(2021*#$?(,2021!:2Zrs0%20%40%60%80%100%0!1!2!3!4!5!6!7!8!(202133%33%2*#$?(8v8vIPO9PLMNO:2&6 a*/+,2#$?(Q3P5!23&P64%*/#$?(QZrs0%20%40%60%80%100%3!5!7!10!#$%&()*+50JK?!8#$%&()*+0LMN?789(:;!178IfU=78IU/78SIUQ.78IUH78I9U.u9Qsf142019!m8vIPO2#$?(LMNOK)-.P12.2%2019!(8vIPO2#$?b-.P9.5%c#$?(LMNOK)1#$?DEaZ%&(LM

13、NOK)aZ%&aZ%&SAAS?bePAId3&c(2K)-.P14.4%#$#$%&-XYPQR?(K)-.P11.6%#$%&-.%&()*+,-OPQR34%&()*+,-OP0STUV7.2%7.2%7.2%11.3%12.2%9.5%15.7%17.0%14.5%#$?R2019!m8vIPO2019!(8vIPO25Z-50Z-75Z-8.0%12.8%6.7%4.2%10.3%14.4%11.6%7.8%15.0%18.8%18.1%14.9%nopSAASPQR-./025Z-50Z-75Z-#$%&-.!1TRRS78915LMq,LMq,*+,2#$?K)2-.P12.8

14、%*/+,2#$?#$?DELMq,rs(LMNOK).XY.XY.XY10nop(K)2-.P13.1%&R-.XY-10n50nopXY(K)2-.P8.9%&RXY#$?DE.XY2rs(LMNOK)(1(K)DE3!;(K)T#$%&RXY#$?DE2rs(LMNOK)8.3%6.5%12.8%10.4%15.4%15.9%*/25Z-50Z-75Z-#$%&-.7.3%5.8%7.1%6.8%13.1%8.9%11.0%11.2%13.9%15.1%15.7%15.8%$10n,$10n-$50nbc$50n-$100nbc$100n25Z-50Z-75Z-#$%&-.6.3%7.0

15、%6.7%8.9%9.9%9.7%15.8%11.2%13.3%15.0%18.3%15.4%3!bc3!-5!bc5!-7!bcDE7!25Z-50Z-75Z-#$%&-.789(?A;!178I=78IQ*/78SIUQRRS783.78I9R17#$3&()2-.P5.3%IPO(3!2!;)-.C2%-3%kO*+,#$?!;)5PY-*/+,#$?CNO2NO-)5#$?jIPO!;)1*/+,*+,2#$?jIPO!;)b-.c%&()*+;P2.5%1.1%1.1%0.8%1.2%5.3%2.9%2.0%2.4%2.2%10.0%5.9%3.5%4.2%4.6%IPO-3IPO-

16、2IPO-1IPO-025Z-50Z-75Z-6.08%4.35%2.00%1.96%1.94%3.21%2.25%1.85%2.89%2.28%IPO-3IPO-2IPO-1IPO-0*/*!178=78Q*Y2/SWUQ+SWUQ182019!(8vIPO2nop3&2019-202!;)-.P1%STLFjGKH&I%2-.P3.3%-3.5%2019!m8vIPO2nop3&2021!;)-.P2.12%LFjGKH&I%-.P5.37%nop3&!;)10.65%0.59%0.80%0.79%1.07%1.11%1.04%2.12%1.49%1.61%1.36%3.63%201920

17、20202120212019!(8vIPO2019!m8vIPO25Z-50Z-75Z-nop3&!;LFjGKg!;H&I%2.26%2.20%1.29%1.90%3.51%3.42%3.26%5.37%4.85%5.22%4.56%14.18%20192020202120212019!(8vIPO2019!m8vIPO25Z-50Z-75Z-_()*5;PABC!1DE,-0QX.3_$#X!.#$0tvwVX.%-978IwX&+9DE4*78Is9DE4*!2RRS783.78I9R19*M%M3Rl49%3&0K%M55%?1L;1*+,#$?2M69%23&0K%M=XIPO%M2

18、K4KU?.VW2%M3*+,2#$?2M%M3PL;234.2%b-.c=XIPO%MaL;2J4J-.C50%ST*+,#$?(M%M311Zrs*+,#$?M%MaL;2J%!#$%&()*+NaDbc34.2%16.2%58.4%47.2%50.2%0%30%60%90%IPO-3IPO-2IPO-1IPO-025Z-50Z-75Z-0%20%40%60%80%0对价极低行权价总价1元注册资本金每股净资产FV评估值普通股价格融资估值上市发行价整体首次授予期权!1RRS783.78I9R20*/+,SAAS?L;a2.2J%*/+,#$?(L31Zrs*/L3Rl38%3&0K31-0K

19、2.OP?;bFVc2.3*/+,#$?L23&K0aL23?U?LVW23*/+,2#$?2.9P31SAAS3&3#$PQR-./0?!8#$%&()*+deBHaDbc0%20%40%60%80%0对价极低行权价总价1元注册资本金每股净资产FV评估值普通股价格融资估值上市发行价整体首次出资入股10.1%12.2%21.5%0%30%60%90%IPO-3IPO-2IPO-125Z-50Z-75Z-!1RRS783.78I9R21*/+,PQR?L;a2.2J%48.2%90.6%100.0%0%30%60%90%120%IPO-3IPO-2IPO-125Z-50Z-75Z-*/+,-./

20、0?L;a2.2J%58.8%33.3%100.0%0%30%60%90%120%IPO-3IPO-2IPO-125Z-50Z-75Z-%&#$HEALTH CAREDEF#$%&()*23?NO|%MMCu2K82%18%3&z0a2L%|fgF?&C1!IPO(3!fklm?&C1!IPO(1!nopfk?&C(IPO(2!u)|%=XIPOu);|*+,wx?u3-e2.7Z2*+,fgF?M3P2.235%STVCF2*+,fgF?M3P2.210%ST?-?NO|%MM2Ka4IPO!;52%2?z60aLzL%|*+,2wx3&z0aL%&CIPO(OfgF3&.2nopST4uK

21、0aLfklm?.22nop84uz0aL&670|49%2*wx?(6:&670!;)|fgF3&!;)TC3%-5%fklm?&C(!fR%24?NO|iZ*+,wx?0K%MMq0aL2C20%ST23&0K0a2L!;)|3VCF2*+,fgF?2021!;)a5X3%(K)|fgF?(K)-.P10.7%OVCF2rs(K)-.14.2%fklm?(K)-.P9.6%nopfk?P7.3%NOaL|wx?(NOaLMNP26.4%OVCF2*+,fgF3&(NOaLMN-.P100%;|=*/+,wx?;3-e12.O7Z2*+,fgF3&XIPO*+,M%Ma2.X50%STVCZ

22、2*+,fgF3&M%Ma2.vTC20%ST25+,-.F.XYZbP-.cwx%&71_3&MNfgF+fklmnopfkaZ%&fgF3&36%2?&Qlicense inPefgF?-2o_18Ade#$?2?85%P+,.XY-.P12.3nop13%2defg3&PVCFO100%2&QPLicense inPefklm?2X3!8vIPO23&iZPAL?.-XYP8.9nop69%P7Z28%P3nopfk?67%P+,.-.P27.4nop(LMq,#ZaZ%&ZrsfgFfklmnopfkALHL医药研发47%医疗器械45%互联网医疗8%36%License in12.38

23、.927.45254565fgFfklmnopfk25Z-50Z-75Z-ZZ医药研发医疗器械互联网医疗个人创立大企孵化VC发起100%Licensein40%Licensein23%License in!1_$AQH!LM3DN.3AQ789pHQH!LM3DN.3()789.*+H!LM3DE.3,-.()789 DNFGOPAQAHQ.DEFG*+Q!2RS78TU8V=RS78SWXYZRS78SWUQ(/0!1#$H78Iw.lJwf/9*+FG)01,-78I2WQsf9*+FG)01,-p”378Iw|79f26*+,2wx?(77%2?0K%M2M41%2?K=OiZ?|(0K

24、2%M2MC(rsU0a2LR%2P26%1*+,wx?(0K2NO177%18%38%15%41%5%10%期权-常规行权价期权-极低行权价限制性股票-0对价限制性股票-非0对价上市前使用该激励工具的企业占比上市前单一使用该激励工具的企业占比26%15%63%100%100%16%50%25%42%25%16%7Z3VCFM-%MM-%ML-0aL-0a*+,2defg3&(0K2NObZDEZc100%23VCF2defg?(-0K6%M2MO100%VCF2defg?0K6%MM0aL2!#$fghij)*+,-./0123427j!;l82%*+,2wx3&0K%M2M18%23&z6

25、0a2L!;%MM2K462%0aL%MM2K#$%MM2Ka(40aL2021!;261%E2020!2021!Z21%13%23&K60a2L=!NOCa;2y*6%MM0aL2*+,2wx3&j2021!10K2NO82%70%18%61%13%0%20%40%60%80%100%IPO-3IPO-2IPO-1IPO-020202021M-%MM-%ML-0aL-0a81%2*/+,2wx?(0KL9PNO*/+,2wx3&(0K2NO81%13%6%3%LM-(%MM-EIPOL!1RH783RSj9.IPO-NHRS78N.78I9p2020A2021789!#$fghij)*+,-

26、./01267!8#$fghij)*+,-./01234(3)(1)13大健康整体医药研发医疗器械互联网医疗25分位50分位75分位(5)(3)(1)HIJWXYZY_aY254b504b754b123456!1DEFG)019.DEFG4RTR28wx?8v%!ST(2!ST4uLMNOOfgF3&C1!b-.cF(3!STb-.cfklm?&C1!ST4uF(1!STnopfk3&%5C(4uR%*+,wx?%“”%12!;b.-!c%wx?%“”F2!;b.-!cFFfgh(9:;?!134567,-.!28V.78I9V.78TQXYnSWUQ9V!3_$Qsfjk929*+,wx3&

27、10aL%“”F2!;b.-!c*+,wx3&0aL%a2?.2XYb.-nopc*+,2wx3&zL%2-.CF%(D!.-XYP8nopSTOfgF3&-C(zL-.CF(!.-.C2nopfklm?zL2%&C(.-.P22nop(3P1!:4!-P2ddPp*wx?(,2021!33Zrs0%20%40%60%80%100%0!1!2!3!5!(2021!#$fgh(9:ABEFGHI0=?!#$fgh()*+50JK?(5)05大健康整体医药研发医疗器械互联网医疗25分位50分位75分位0102030大健康整体医药研发医疗器械25分位50分位75分位49%!1_$Qsf930*wx?

28、(,2021!:1Zrs49%2*wx?(2LMNOC&6702a*/+,2wx?(:/Q3P3!23&P33%*/wx?(:/QZrs0%20%40%60%80%100%0!1!2!3!4!5!6!7!8!(2021C=&67023&g79%23&8vIPO9Pd&67021%23&8vgeF29P&670OiZ?.+Q9P&67079%21%16%11%11%IPO项目里程碑市值目标融资目标财务指标0%10%20%30%40%50%1!2!3!4!5!6!8#$fgh()*+0LMN?789(:;!178IfU=78IU/78SIUQ.78IUH78I9U.u9Qsf31wx%&R(LMN

29、OK)-.P9.6%OfgF3&-.XYP10.7%nopfk3&-.XYP7.3%75Z-XY17.3%wxaZ%&(LMNOK)1fgF?DELMq,(LMNOK)DELMq,DELMq,fgF?(LMNOK)-.CDELMq,2rsD6.3%5.1%10.7%9.8%14.8%19.8%HL25Z-50Z-75Z-fgh()*+,-OPQR34klmnij)*+,-OP0STUV5.0%5.2%4.3%5.3%9.6%10.7%9.6%7.3%14.8%14.8%13.6%17.3%wxRfgFfklmnopfk25Z-50Z-75Z-32fgF?DEZ(LMNOK)DEZDEZVCF2

30、fgF?(K)a5-.P14.2%7Zrs(2NOK)-.P7.3%a54.2%11.1%13.5%7.3%12.0%14.2%13.7%14.0%15.8%7Z3VCF25Z-50Z-75Z-fklm?DELMq,(LMNOK)DELMq,DELMq,+,2fklm?(LMNOK)-.a5P12.8%HL2fklm?(NOK)-.P10.2%AL2)a5-.P5.9%DEZDEZ32fklm?(NOK)a-.P8.5%fklm?DEZ(LMNOK)kopqij)*+,-OP0STUV9.0%9.8%3.5%12.8%10.2%5.9%17.0%16.8%11.0%HLAL25Z-50Z-75

31、Z-4.6%4.2%9.0%8.5%17.7%12.1%7Z325Z-50Z-75Z-789(?A;!1*VRTmIPO-NT.IPO-N9mV35gwx?2-IPO-3!;)-.P2.0%XIPO%4uR%g!;)XYgwx?IPO!;84uR%!;)-.P5.0%fgF3&(!;)P3%-5%fklm?IPO(!)sfnopfk?(3!g!sfwx?%CDE!;rs2!;)11.2%1.1%1.9%1.6%2.0%2.5%4.3%5.0%4.8%3.4%7.0%7.3%IPO-3IPO-2IPO-1IPO-025Z-50Z-75Z-wx?DEaZ%&(!;)b-.cfgh()*+z;P3.

32、8%2.5%3.8%5.0%1.4%3.3%6.1%1.8%4.7%1.3%2.8%4.2%IPO-3IPO-2IPO-1IPO-0fgFfklmnopfk36!178=78Q*Y2/SWUQ+SWUQ!#$0fgh()*5;P1.00%1.19%0.85%2.67%3.10%1.92%3.53%5.21%2.70%20192020202125Z-50Z-75Z-*+,2wx?2019-2021!;)1*+,2wx3&2021!)-.P1.92%j*+,fgF3&2021!)l3VCF22021!)XYa7Z2-.XYX3%*+,2fgF?2021!;)11.03%0.51%2.56%2.28

33、%2.25%1.03%2.86%2.73%2.98%1.80%3.09%3.68%fgFR7Z3VCF25Z-50Z-75Z-ABC!1DE,-0QX.3_$#X!.#$0tvwVX37*M%M3Rl61%2*+,wx?12.*+,wx?M52%3&%MU2.VWjM%Ma2.2l=XIPO%Ma2.J2-.XYIPOg!50.8%*+,wx?(M%M311Zrs*+,wx?M%Ma2.2J%0%20%40%60%80%0对价极低行权价总价1元注册资本金每股净资产FV评估值普通股价格融资估值上市发行价整体首次授予期权30.8%29.5%33.7%50.8%0%20%40%60%80%100%I

34、PO-3IPO-2IPO-1IPO-025Z-50Z-75Z-!#$fgh()*+NaDbc38*+,7Z2fgF?M%Ma2.2J1%7Z2fgF?(%Ma2.-.TC50%STVCF2fgF?(%M3a2.-.P10%-20%*+,VCF2fgF?M%Ma2.2J%14.0%10.0%26.0%19.3%0%30%60%90%IPO-3IPO-2IPO-1IPO-025Z-50Z-75Z-!#$klmn()*+NaDbc35.0%71.8%49.7%55.1%50.8%0%30%60%90%IPO-3IPO-2IPO-1IPO-025Z-50Z-75Z-!1RH783RSj9.IPO-NH

35、RS78N.78I939*/+,wx?L;a2.2J%19.4%50.0%22.3%0%30%60%90%IPO-3IPO-2IPO-125Z-50Z-75Z-*/L3Rl61%2*/+,wx?12.*/+,wx?L46%3&L3U2.VWjL;a2.2l=XIPOL;a2.J275Z-.XY-.XY-20%-40%*/+,wx?(L%M31Zrs!8#$fgh()*+deBHaDbc0%20%40%60%80%0对价极低行权价总价1元注册资本金每股净资产FV评估值普通股价格融资估值上市发行价整体首次出资入股()*#$CONSUMERGHI#$%&()*41?,-./|*+,2?%MMCu2K

36、60%C40%2?*(KL 9:;|?&CIPO(3!4uLMNOO2?P=XIPO|;P|)-.C1.2%ST;D|*+,?eL;R%M3*/+,?eL2.R%3?-?NO|%MM2KTC60%IPO!;0aL2K&670|40%2*?(8vIPO9P:&670!;)|?(!;)XYTC1%-2%(K)|?(NOK)-.P7.0%a#$O&Q2?(XY(242?NO|*+,?0KM2#$4e0K0a2LNOaL|?(NOaLMNP1.7%O2?(NO75-.P1147;|*+,2?2M%MaL;2TC100%*/+,2?L;a2.2TC50%ST43+,-.F.XYZ%&32_3&MN+oa

37、Z%&78%2?-P2019!m8vIPO50%2%&P*+,Co(-C*/+,2Eo.3&5j&Q2ZloaEnop(RR%IP2+2H(LMq,#ZaZ%&Zrs&Q!Z食品饮料美妆个护服饰 餐饮 潮玩 综合境外境内食品饮料美妆个护服饰 餐饮 潮玩 综合大于$50亿$10亿-$50亿$5亿-$10亿(含)$5亿及以下31%13%16%13%6%22%o!1DEFGH78IJK!LM3DE.DNFGH78IJK!LM3DN!2RS78TU8V=RS78SWXYZRS78SWUQ!3-89H-8:;9?HA?IP9CC.DEHF7FG9HIDEJKnLM.NOHFGNO9?PAQRo Mcde

38、fg(/044*+,2?(93%2?0K6ML20%23&K6LCKML23&g57%2?0K%M2M=!NODCK%MM2rsa2019!(8vIPO2?2019!m8vIPO2?M2?P44%a2019!(8vIPO2?#$4L2KS*+,?(0K2NO1!#$()*+,-./0ML 21%L 21%M57%!1_$9BaQbOcQdefSAgBaQbRSghTijk9BaQblmRSUnh-ojk9BaQblmPRSUpqrWsXtHuvwxyzWsX|E9X9WsXpSW-$9BaQb0X9BaQb2019!(8vIPO2*+,?(0K2NO44%80%22%20%33%2019?IP

39、O2019?IPO?(/045*+,?(MPeVW=XIPO,IPO%M2MK40a2LK!#$()*+5,-./0670%20%40%60%80%100%IPO-3IPO-2IPO-1IPO-02021MLL*+,23&j2021!10K2NO!1RHIPO39RT.IPO-NHRS78N.78I9p2021789 12345646jaZ%&l112(%“”IPO%P=(j&Ql2?%&CIPO(4!STb-.c2?%&CIPO(1-2!STH2?%P=(&CIPO(5!b-.c?%“”F2!;DE&Qb.-!c(9:;(8)(6)(4)(2)0R25Z-50Z-75Z-?%“”F2!;DE

40、%&b.-!c(8)(6)(4)(2)0Ro25Z-50Z-75Z-47*+,?(2:0%10%20%30%40%50%0!1!2!3!4!5!6!7!(40%2*+,?(8vIPO9P&6!#$(JK?(3b-!c(3P1!:P4!-P2dk0%20%40%60%80%100%0!1!2!3!(!1_$Qsf9789(:;!178IfU=78IU/78SIUQ.78IUH78I9U.u9Qsf48%&R(LMNOK)-.P5.0%O2019!m8vIPO2?58vIPO2?(K)#$-.XY7.0%&(LMNOK)1?DEaZ%&(LMNOK)DEaZ%&DEaZ%&o1(NOK)5-.-1

41、0%ST1(NOK)-.C7%ST1(NOK)-.C3%-4%()*+,-OP2.9%2.9%1.7%5.0%7.0%2.6%9.2%11.4%4.5%R2019!m8vIPO2019!(8vIPO25Z-50Z-75Z-()*+,-OP0STUV2.9%10.3%4.0%9.9%6.7%7.3%0%2%4%6%8%10%12%14%16%o25Z-50Z-75Z-!178IT78IRRSIPO949?DE&Q(LMNOK)DE&QDE&QIP2?(NOK)a5-.P6.8%75Z-.12.9%H2?(NOK)-.P7%Pe2?(NOK)P2.5%DE.XYDE.XY3&.XY5()a5g.X

42、YDE5nop(NOK)D-.C5%STDEDE13&(NOK)6.8%2.5%7.0%0%2%4%6%8%10%12%14%25Z-50Z-75Z-?DE.XY(LMNOK)15.9%4.0%5.0%5.0%0%5%10%15%20%25%$5n,$5n-$10nbc$10n-$50nbc$50n25Z-50Z-75Z-?DE(LMNOK)2.5%4.8%6.9%14.9%0%5%10%15%20%3!bc3!-5!bc5!-7!bcDE7!25Z-50Z-75Z-789(?A;!1*VRTmIPO-NT.IPO-N9mV.RIPO3978I!278=78Q*Y2/SWUQ+SWUQ523&

43、;5=XIPO!;2)41%ST*/+,2?VW=XIPO!;!;)4*+,2?=XIPO!;!;)vTC1%-2%?jIPO!;2!;)1()*+z;P1.2%1.7%1.3%1.2%1.1%0%1%2%3%4%5%IPO-3IPO-2IPO-1IPO-025Z-50Z-75Z-*/*?jIPO!;2!;)b.P-.c0%1%1%2%2%3%3%IPO-3IPO-2IPO-1IPO-0*/*ABC!1DE,-0QX.3_$#X!.#$0tvwVX53*M%M3Rl50%2*+,?(M3L3b.!PL2.231cj(M3aL;2lM3-L;2100%*+,?(M%M311Zrs*+,?M%Ma

44、L;2J%!#$()*+NaDbc0%20%40%60%80%0对价极低行权价总价1元注册资本金每股净资产FV评估值普通股价格融资估值上市发行价整体首次授予期权102.4%96.2%101.7%45.2%106.9%IPO-3IPO-2IPO-1IPO-025Z-50Z-75Z-54*/L3Rl38%23&L9P3138%23&2.9P31=XIPO2.9P312j(L3a2.2lL3-2.250%ST*/+,?(L%M31Zrs*/+,La2.2J%!8#$()*+NaDbc0%20%40%60%80%0对价极低行权价总价1元注册资本金每股净资产FV评估值普通股价格融资估值上市发行价整体首次

45、出资入股50.2%50.5%48.6%62.1%42.8%0%30%60%90%IPO-3IPO-2IPO-1IPO-025Z-50Z-75Z-!#$%&!#$%&#$%&()*+,-./0123456789:;#$%&?AB+SaaSCDEFGHIJKLM4567NOPQRDS,TUVWXIYZ_abcdefghefijklmnOoUbrasBuffXp#$%&qrstuvwxyzAB|d2st&p|2*XIJKS,DABTUDTUABOUT LINGDONGWEILAILINGDONGWEILAIempowersenterprisestogrowandflourishthroughvari

46、ousstages,byunleashing the full potential of stockincentive plan.We specialize in fulllifecycle consulting&SaaS solutionsoncutting-edgestockincentiveservices.OurclientsincludeXiaopeng,LIZHI,Envision,NARWAL,FOSUNPharma,Arctic Vision,Ubras,BuffX,etc.we are committed tosupportcompanieswithindustryleadi

47、ng services.!x!xx“”*),D|2+,&DND,-D,2xSkGD17&2x900w,EF./*D+,About Sequoia ChinaSequoia China helps daring foundersbuildlegendarycompanies.Inpartnering with Sequoia,companiesbenefitfromourunmatchedcommunity and the lessons wevelearned over the years.As“TheEntrepreneursBehindTheEntrepreneurs”,SequoiaCh

48、inafocusesonthreesectors:tech,healthcare and consumer.Over thepast 17 years weve had the privilegeofworkingwithmorethan900companies in China.!#$%&()*+,-./0123456)789%&:;?ABCD;EFG%&(HI56JK LMN*+)OPQJRSQT7UVWXYZ=)9%&;()56JKL,*+A_(a)bcYd e_f)ghigETjkXYlPF%&(HTmUVnopq%&:)rsO56FItu56)ghYhvTw xyz9$%&;|)H*+569$%&:;=)56TJJJ“”YdeFT0mUV)+F+$%&;()56MN;)y;)ayF%&(Hu9

展开阅读全文
相似文档                                   自信AI助手自信AI助手
猜你喜欢                                   自信AI导航自信AI导航
搜索标签

当前位置:首页 > 行业资料 > 其他

移动网页_全站_页脚广告1

关于我们      便捷服务       自信AI       AI导航        获赠5币

©2010-2024 宁波自信网络信息技术有限公司  版权所有

客服电话:4008-655-100  投诉/维权电话:4009-655-100

gongan.png浙公网安备33021202000488号   

icp.png浙ICP备2021020529号-1  |  浙B2-20240490  

关注我们 :gzh.png    weibo.png    LOFTER.png 

客服